Document is current
Any future updates will be listed below
-
Authors
Thomas, Ranjeeta http://orcid.org/0000-0002-0947-4574
Skovdal, Morten
Galizzi, Matteo M.
Schaefer, Robin
Moorhouse, Louisa
Nyamukapa, Constance
Maswera, Rufurwokuda
Mandizvidza, Phyllis
Hallett, Timothy B.
Gregson, Simon
-
Funding
Funding for this research was provided by:
National Institute of Mental Health (R01MH114562-01)
Bill and Melinda Gates Foundation (OPP1161471)
UK Medical Research Council (MR/R015600/1)
- License Information
-
More Information
Article History
Received: 28 May 2019
Accepted: 5 October 2019
First Online: 2 December 2019
Ethics approval and consent to participate
: As described above, this study has been approved by the Medical Research Council of Zimbabwe (Ref. MRCZ/A/2243), Biomedical Research and Training Institute Zimbabwe Institutional Review Board (Ref. AP140/2017), and the Imperial College London Research Ethics Committee (Ref. 17IC4160). Each participant will provide written informed consent before the initiation of baseline assessments or the intervention.
: Not applicable.
: SG declares shares in GlaxoSmithKline and AstraZeneca. TBH declares grants outside the subject area from: UNAIDS, WHO, BMGF, MRC. RT declares grants outside the subject area from EDCTP. The other authors declare that they have no competing interests.
